无标定检测市场规模、份额及成长分析（按产品、技术、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，无标定检测市场规模将达到 15.2 亿美元，到 2025 年将达到 16.5 亿美元，到 2033 年将达到 31.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.5%。

无标定检测系统是一种创新的整合技术，无需依赖萤光或标记技术即可分析生物分子间的相互作用。这些系统为药物发现提供了一种快速、即时的方法，并在生化和细胞分析中有广泛的应用。无标定检测市场正呈现强劲成长势头，这主要得益于先进技术产品的推出以及产学研合作的日益密切，从而推动了药物倡议。其他推动市场扩张的因素包括研究经费的增加以及无标定技术卓越的灵敏度。此外，製药和生物技术领域研发活动的日益重要，以及终端用户对无标定检测方法优势的认识不断提高，预计都将显着促进该行业的成长。

无标定检测市场驱动因素

新兴市场生命科学研究的进步以及更灵敏、无标记技术的持续发展，推动了无标定检测市场显着成长。这种快速成长为企业提供了众多创新机会，以满足日益增长的高效产品需求。最尖端科技产品的推出，使得人们能够探索分子相互作用，而无需面对标记带来的复杂问题，例如猝灭效应。此外，无标定技术作为高通量筛检领域相对较新的技术，能够研究生物分子相互作用，避免空间干扰或萤光的影响，从而提高分析的准确性和效率。

限制无标定检测市场的因素

无标定检测市场的成长受到高成本的显着限制。此外，潜在使用者群体对无标定检测技术的广泛应用，使其无法充分发挥潜力。因此，除非这些限制因素得到解决，否则无标定检测市场可能难以实现显着成长并在各个应用领域中广泛应用。

无标定检测市场趋势

由于技术的快速发展和策略合作，无标定检测市场正经历显着成长。生物层干涉（BLI）和表面等离子体共振（SPR）等创新技术正在提升检测系统的性能，使其更易于研究人员使用，效率更高。特别是，康宁® Epic® BT 等紧凑型桌上型侦测仪的推出，凭藉其用户友好的介面和经济高效的设计，正在革新检测流程。康宁与 Advenus Therapeutics 等公司之间的伙伴关係，正在促进这些先进技术的更广泛应用，并拓展其在药物发现和检测方法开发中的应用范围。这种协同效应有望推动市场实现前所未有的扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

全球无标定检测市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 消耗品
  • 生物感测器晶片
  • 微孔盘
• 装置

全球无标定检测市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 生物层干涉测量
• 差示扫描量热法
• 等温滴定量检测法
• 表面等离子体共振
• 质谱分析
• 其他无标定检测技术

全球无标定（按应用领域及复合年增长率划分）（2026-2033 年）

• 结合动力学
• 键动态
• 内源性受体检测
• 命中确认
• 潜在客户开发
• 其他的

全球无标定检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 学术和研究机构
• CRO（合约研究组织）

全球无标定检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Agilent Technologies, Inc.（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• GE Healthcare（USA）
• Thermo Fisher Scientific Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Horiba, Ltd.（Japan）
• Malvern Panalytical Ltd.（UK）
• Bruker Corporation（USA）
• Waters Corporation（USA）
• Shimadzu Corporation（Japan）
• Corning Incorporated（USA）
• Hitachi High-Tech Corporation（Japan）
• Molecular Devices, LLC（USA）
• Sartorius AG（Germany）
• BiOptix Analytical LLC（USA）
• Attana AB（Sweden）
• XanTec Bioanalytics GmbH（Germany）

结论与建议

Label Free Detection Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.65 Billion in 2025 to USD 3.17 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

Label-free detection systems are innovative integrated technologies that allow for the examination of biomolecular interactions without relying on fluorescence or labeling techniques. These systems offer a rapid and real-time method for drug discovery, with key applications in biochemical and cell-based assays. The label-free detection market is witnessing robust growth, driven by the launch of advanced technological products and an increase in academic-industrial collaborations that boost drug discovery initiatives. Additional factors fueling market expansion include heightened research funding and the remarkable sensitivity of label-free technologies. Furthermore, the growing focus on pharmaceutical and biotechnology R&D activities, coupled with rising awareness among end-users regarding the advantages of label-free detection methods, is expected to significantly enhance industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Label Free Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Label Free Detection Market Segments Analysis

Global Label Free Detection Market is segmented by product, technology, application, end-user and region. Based on product, the market is segmented into consumables and instruments. Based on technology, the market is segmented into bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, surface plasmon resonance, mass spectrometry and other LFD technologies. Based on application, the market is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation and other. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Label Free Detection Market

The label-free detection market is experiencing significant growth due to advancements in life sciences research in emerging markets and the ongoing development of more sensitive non-marker technologies. This surge presents numerous opportunities for companies to innovate and cater to the increasing demand for efficient product delivery. The introduction of state-of-the-art technological products facilitates the exploration of molecular interactions without the complications associated with labels, such as quenching effects. Furthermore, label-free technologies, while relatively novel in the established domain of high-throughput screening, enable researchers to investigate biomolecular interactions without the hindrances of spatial interference or autofluorescence, thereby enhancing analysis accuracy and effectiveness.

Restraints in the Label Free Detection Market

The growth of the label-free detection market is considerably restricted by the high costs associated with the necessary instruments for this technology. Additionally, a notable barrier to the market's development is the limited awareness among potential users regarding the benefits that label-free detection offers. This combination of expensive equipment and insufficient understanding of its advantages hinders broader adoption and impedes the market's ability to reach its full potential. As a result, without addressing these constraints, the label-free detection market may struggle to achieve significant growth and wider implementation in various applications.

Market Trends of the Label Free Detection Market

The Label-Free Detection market is witnessing significant growth driven by rapid technological advancements and strategic collaborations. Innovations such as Bio-layer Interferometry (BLI) and Surface Plasmon Resonance (SPR) are enhancing the capabilities of detection systems, making them more accessible and efficient for researchers. Notably, the introduction of compact benchtop models, like the Corning(R) Epic(R) BT, is revolutionizing assay processes with user-friendly interfaces and cost-effective designs. Partnerships between companies, such as Corning and Advinus Therapeutics, facilitate wider adoption of these advanced technologies, thereby expanding their application in drug discovery and assay development. This synergy is set to propel the market towards unprecedented expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Label Free Detection Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Biosensor Chips
  • Microplates
• Instruments

Global Label Free Detection Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bio-Layer Interferometry
• Differential Scanning Calorimetry
• Isothermal Titration Calorimetry
• Surface Plasmon Resonance
• Mass Spectrometry
• Other LFD Technologies

Global Label Free Detection Market Size by Application & CAGR (2026-2033)

• Market Overview
• Binding Kinetics
• Binding Thermodynamics
• Endogenous Receptor Detection
• Hit Confirmation
• Lead Generation
• Other

Global Label Free Detection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Global Label Free Detection Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Malvern Panalytical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi High-Tech Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiOptix Analytical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Attana AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XanTec Bioanalytics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations